Joga Gobburu Selected Research

FLAM regimen

7/2017

Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joga Gobburu Research Topics

Disease

2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2008 - 06/2003
2	Philadelphia Chromosome 01/2008 - 06/2003
2	Blast Crisis (Blast Phase) 01/2008 - 06/2003
1	Hemolysis 03/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2022
1	Inflammation (Inflammations) 01/2021
1	Leukemia 07/2017
1	Major Depressive Disorder (Major Depressive Disorders) 01/2014
1	Hemorrhage 01/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2008

Drug/Important Bio-Agent (IBA)

2	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2017 - 06/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2008 - 06/2003
1	Heparin (Liquaemin)FDA LinkGeneric 03/2022
1	Tyrosine Kinase InhibitorsIBA 03/2022
1	AnticoagulantsIBA 03/2022
1	cabozantinibIBA 03/2022
1	ziltivekimabIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2017
1	alvocidib (flavopiridol)IBA 07/2017
1	Escitalopram FDA Link 01/2014
1	Citalopram FDA LinkGeneric 01/2014
1	Dasatinib (BMS 354825)FDA Link 01/2008
1	Phosphotransferases (Kinase)IBA 01/2008
1	Tyrosine (L-Tyrosine)FDA Link 01/2008
1	Pharmaceutical PreparationsIBA 06/2003

Therapy/Procedure

1	FLAM regimen 07/2017
1	Therapeutics 01/2008